![Bernhard R. M. Ehmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernhard R. M. Ehmer
Chairman at
BIOTEST GMBH & CO. KGAA
Profile
Bernhard R.
M.
Ehmer is currently Chairman-Supervisory Board at Biotest GmbH & Co. KGaA since 2022, Chairman at Swarm Oncology Ltd., Independent Non-Executive Director at Achilles Therapeutics Plc since 2022, Independent Member-Supervisory Board at Affimed NV since 2016, and Member-Supervisory Board at Affimed GmbH since 2016.
Former roles include Chief Executive Officer & Managing Director at Biopheresis GmbH and BioPheresis Technologies, Inc. from 2006 to 2007, President & Chief Executive Officer at Neovii Biotech GmbH from 2007 to 2008, Chairman-Management Board at Biotest GmbH & Co. KGaA. from 2014 to 2019, Chairman at Servier Symphogen.
A from 2018 to 2020, Director at ADMA Biologics, Inc. from 2017 to 2018, Director at Aton SA, Managing Director & Senior Vice President at ImClone Systems International GmbH from 2008 to 2012, VP, Head-Strategic Planning & Alliance Management at Merck KGaA from 1988 to 2006, Head-Therapeutics & Medical Operations at Boehringer Mannheim GmbH from 1986 to 1998, and President at ImClone Systems Corp.
from 2009 to 2014.
Education includes undergraduate degrees from Ruprecht-Karls-Universität Heidelberg and Ludwig-Maximilians-Universität München, both conferred in 1982.
Bernhard R. M. Ehmer active positions
| Companies | Position | Start |
|---|---|---|
| AFFIMED N.V. | Director/Board Member | 2016-01-20 |
| ACHILLES THERAPEUTICS PLC | Director/Board Member | 2022-05-03 |
| BIOTEST GMBH & CO. KGAA | Chairman | 2022-05-04 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Director/Board Member | 2015-12-31 |
Former positions of Bernhard R. M. Ehmer
| Companies | Position | End |
|---|---|---|
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Chairman | 2020-05-31 |
| BIOTEST GMBH & CO. KGAA | Chief Executive Officer | 2019-03-31 |
| ADMA BIOLOGICS, INC. | Director/Board Member | 2018-02-14 |
ImClone Systems Corp.
 ImClone Systems Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | President | 2014-09-30 |
ImClone Systems International GmbH
 ImClone Systems International GmbH BiotechnologyHealth Technology Develops novel therapeutic products | Corporate Officer/Principal | 2011-12-31 |
Training of Bernhard R. M. Ehmer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Biotest AG
 Biotest AG Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes therapy medicinal products | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Biopheresis GmbH
 Biopheresis GmbH Miscellaneous Commercial ServicesCommercial Services Provides cancer treatments | Commercial Services |
BioPheresis Technologies, Inc.
 BioPheresis Technologies, Inc. Medical SpecialtiesHealth Technology Develops technology and medical devices for the treatment of cancer | Health Technology |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Boehringer Mannheim GmbH | |
ImClone Systems International GmbH
ImClone Systems International GmbH BiotechnologyHealth Technology Develops novel therapeutic products | Health Technology |
ImClone Systems Corp.
ImClone Systems Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Bernhard R. M. Ehmer
